[Comment] Updated WHO recommendation on intravenous tranexamic acid for the treatment of…

The following two tabs change content below.
Lancet Global Health
The Lancet Global Health is The Lancet's first gold open-access title and focuses on original research, commentary, correspondence and blogs on topics including maternal and child health, infectious and noncommunicable diseases, mental health, and more. The Editor is Zoë Mullan.

Post-partum haemorrhage is the leading cause of maternal mortality globally.1 The majority of deaths resulting from post-partum haemorrhage occur during the first 24 h after birth, most of which could be avoided by routine prevention through active management of the third stage of labour and prompt and effective management of post-partum haemorrhage, including the use of uterotonics and fluid replacement. Tranexamic acid, an antifibrinolytic drug, was identified as a promising candidate to be included in recommended packages for treatment of post-partum haemorrhage, since it has shown efficacy in reducing blood loss and mortality following surgical trauma.

Source:  

[Comment] Updated WHO recommendation on intravenous tranexamic acid for the treatment of…